T cell-derived IL-10 and its impact on the regulation of host responses during malaria

International Journal for Parasitology

Volumn 42, Issue 6, 2012, Pages 549-555

  Freitas do Rosario, Ana Paula ^a   Langhorne, Jean ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Foxp3+ Treg cells; Interleukin 10; Malaria; Th1 CD4+ cells; Tr1 cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 27; TRANSCRIPTION FACTOR FOXP3;

DISEASE CONTROL; IMMUNE SYSTEM; INFECTIOUS DISEASE; MALARIA; PARASITIC DISEASE; PATHOLOGY;

ADAPTIVE IMMUNITY; BRAIN MALARIA; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE CONTROL; HUMAN; IMMUNE RESPONSE; LEISHMANIASIS; MALARIA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-10; MALARIA; PRIMATES; RODENTIA; TH1 CELLS;

PRIMATES; RODENTIA;

EID: 84861680926     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.03.010     Document Type: Review

References (119)

1. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 2007, 204:285-297.
2. Anderson C.F., Lira R., Kamhawi S., Belkaid Y., Wynn T.A., Sacks D. IL-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J. Immunol. 2008, 180:4090-4097.
3. + cells in nonhealing Leishmania major infection. J. Immunol. 2009, 183:4619-4627.
4. Andrade B.B., Reis-Filho A., Souza-Neto S.M., Clarencio J., Camargo L.M., Barral A., Barral-Netto M. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar. J. 2010, 9:13.
5. Ansari N.A., Kumar R., Gautam S., Nylen S., Singh O.P., Sundar S., Sacks D. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J. Immunol. 2011, 186:3977-3985.
6. Armah H.B., Wilson N.O., Sarfo B.Y., Powell M.D., Bond V.C., Anderson W., Adjei A.A., Gyasi R.K., Tettey Y., Wiredu E.K., Tongren J.E., Udhayakumar V., Stiles J.K. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 2007, 6:147.
7. Awandare G.A., Goka B., Boeuf P., Tetteh J.K., Kurtzhals J.A., Behr C., Akanmori B.D. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J. Infect. Dis. 2006, 194:1438-1446.
8. Ayimba E., Hegewald J., Segbena A.Y., Gantin R.G., Lechner C.J., Agosssou A., Banla M., Soboslay P.T. Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria. Clin. Exp. Immunol. 2011, 166:218-226.
9. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 2005, 17:279-288.
10. Battaglia M., Stabilini A., Draghici E., Gregori S., Mocchetti C., Bonifacio E., Roncarolo M.G. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006, 55:40-49.
11. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
12. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 2009, 27:551-589.
13. Braat H., Rottiers P., Hommes D.W., Huyghebaert N., Remaut E., Remon J.P., van Deventer S.J., Neirynck S., Peppelenbosch M.P., Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 2006, 4:754-759.
14. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006, 12:1301-1309.
15. + regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One 2009, 5:e9623.
16. +) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int. J. Parasitol. 2008, 38:229-238.
17. Chatenoud L., Bach J.F. Adaptive human regulatory T cells: myth or reality?. J. Clin. Invest. 2006, 116:2325-2327.
18. Chen G., Liu J., Wang Q.H., Wu Y., Feng H., Zheng W., Guo S.Y., Li D.M., Wang J.C., Cao Y.M. Effects of CD4(+)CD25(+)Foxp3(+)regulatory T cells on early Plasmodium yoelii 17XL infection in BALB/c mice. Parasitology 2009, 136:1107-1120.
19. Coombes J.L., Robinson N.J., Maloy K.J., Uhlig H.H., Powrie F. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 2005, 204:184-194.
20. Couper K.N., Blount D.G., Wilson M.S., Hafalla J.C., Belkaid Y., Kamanaka M., Flavell R.A., de Souza J.B., Riley E.M. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 2008, 4:e1000004.
21. Cox-Singh J., Singh B., Daneshvar C., Planche T., Parker-Williams J., Krishna S. Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi infections. PLoS One 2011, 6:e20541.
22. Deckert M., Soltek S., Geginat G., Lutjen S., Montesinos-Rongen M., Hof H., Schluter D. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect. Immun. 2001, 69:4561-4571.
23. Ejrnaes M., Filippi C.M., Martinic M.M., Ling E.M., Togher L.M., Crotty S., von Herrath M.G. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006, 203:2461-2472.
24. Findlay E.G., Greig R., Stumhofer J.S., Hafalla J.C., de Souza J.B., Saris C.J., Hunter C.A., Riley E.M., Couper K.N. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 2010, 185:2482-2492.
25. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-20095.
26. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., Saris C.J., Gran B., Ciric B., Rostami A. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007, 8:1372-1379.
27. Flanagan K.L., Plebanski M., Odhiambo K., Sheu E., Mwangi T., Gelder C., Hart K., Kortok M., Lowe B., Robson K.J., Marsh K., Hill A.V. Cellular reactivity to the P. falciparum protein trap in adult kenyans: novel epitopes, complex cytokine patterns, and the impact of natural antigenic variation. Am. J. Trop. Med. Hyg. 2006, 74:367-375.
28. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
29. + T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 2012, 188:1178-1190.
30. + T cells and accompanied by overproduction of IL-12, IFN-gamma, and TNF-alpha. J. Immunol. 1996, 157:798-805.
31. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., Muller I. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008, 5:e127.
32. Giusti P., Urban B.C., Frascaroli G., Albrecht L., Tinti A., Troye-Blomberg M., Varani S. Plasmodium falciparum-infected erythrocytes and beta-hematin induce partial maturation of human dendritic cells and increase their migratory ability in response to lymphoid chemokines. Infect. Immun. 2011, 79:2727-2736.
33. + regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?. Infect. Immun. 2010, 78:4763-4772.
34. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
35. + natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 2010, 6:e1001221.
36. Haribhai D., Williams J.B., Jia S., Nickerson D., Schmitt E.G., Edwards B., Ziegelbauer J., Yassai M., Li S.H., Relland L.M., Wise P.M., Chen A., Zheng Y.Q., Simpson P.M., Gorski J., Salzman N.H., Hessner M.J., Chatila T.A., Williams C.B. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011, 35:109-122.
37. Haringer B., Lozza L., Steckel B., Geginat J. Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J. Exp. Med. 2009, 206:1009-1017.
38. Hawrylowicz C.M., O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 2005, 5:271-283.
39. Hirunpetcharat C., Finkelman F., Clark I.A., Good M.F. Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol. 1999, 21:319-329.
40. + regulatory T cells. Nat. Med. 2004, 10:29-30.
41. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 1997, 158:3311-3316.
42. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 1999, 162:5317-5326.
43. Jangpatarapongsa K., Chootong P., Sattabongkot J., Chotivanich K., Sirichaisinthop J., Tungpradabkul S., Hisaeda H., Troye-Blomberg M., Cui L., Udomsangpetch R. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur. J. Immunol. 2008, 38:2697-2705.
44. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007, 204:273-283.
45. Joss A., Akdis M., Faith A., Blaser K., Akdis C.A. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 2000, 30:1683-1690.
46. Kabyemela E.R., Muehlenbachs A., Fried M., Kurtis J.D., Mutabingwa T.K., Duffy P.E. Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria. Malar. J. 2008, 7:26.
47. Kobayashi F., Morii T., Matsui T., Fujino T., Watanabe Y., Weidanz W.P., Tsuji M. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii. Parasitol. Res. 1996, 82:385-391.
48. Kossodo S., Monso C., Juillard P., Velu T., Goldman M., Grau G.E. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 1997, 91:536-540.
49. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
50. Kurtzhals J.A.L. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998, 351:1768-1772.
51. + regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007, 204:57-63.
52. Legorreta-Herrera M., Rivas-Contreras S., Ventura-Gallegos J., Zentella-Dehesa A. Nitric Oxide is Involved in the Upregulation of IFN-gamma and IL-10 mRNA Expression by CD8 T Cells During the Blood Stages of P. chabaudi AS Infection in CBA/Ca Mice. Int. J. Biol. Sci. 2011, 7:1401-1411.
53. Li C., Corraliza I., Langhorne J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun 1999, 67:4435-4442.
54. Li C., Sanni L.A., Omer F., Riley E., Langhorne J. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. Infect. Immun. 2003, 71:4850-4856.
55. Linke A., Kuhn R., Muller W., Honarvar N., Li C., Langhorne J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 1996, 84:253-263.
56. + T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 2003, 33:175-183.
57. Lyke K.E., Burges R., Cissoko Y., Sangare L., Dao M., Diarra I., Kone A., Harley R., Plowe C.V., Doumbo O.K., Sztein M.B. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 2004, 72:5630-5637.
58. Madan R., Demircik F., Surianarayanan S., Allen J.L., Divanovic S., Trompette A., Yogev N., Gu Y., Khodoun M., Hildeman D., Boespflug N., Fogolin M.B., Grobe L., Greweling M., Finkelman F.D., Cardin R., Mohrs M., Muller W., Waisman A., Roers A., Karp C.L. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 2009, 183:2312-2320.
59. Magnani C.F., Alberigo G., Bacchetta R., Serafini G., Andreani M., Roncarolo M.G., Gregori S. Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur. J. Immunol. 2011, 41:1652-1662.
60. - precursor cells in the absence of interleukin 10. Nat. Immunol. 2007, 8:931-941.
61. Maynard C.L., Weaver C.T. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol. Rev. 2008, 226:219-233.
62. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
63. Medina T.S., Costa S.P., Oliveira M.D., Ventura A.M., Souza J.M., Gomes T.F., Vallinoto A.C., Povoa M.M., Silva J.S., Cunha M.G. Increased interleukin-10 and interferon-gamma levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar. J. 2011, 10:264.
64. Minigo G., Woodberry T., Piera K.A., Salwati E., Tjitra E., Kenangalem E., Price R.N., Engwerda C.R., Anstey N.M., Plebanski M. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 2009, 5:e1000402.
65. Moore K.W., De Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 2001, 19:683-765.
66. Moormann A.M., John C.C., Sumba P.O., Tisch D., Embury P., Kazura J.W. Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area. Am. J. Trop. Med. Hyg. 2006, 74:585-590.
67. Moormann A.M., Sumba P.O., Tisch D.J., Embury P., King C.H., Kazura J.W., John C.C. Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. Am. J. Trop. Med. Hyg. 2009, 81:489-495.
68. Nagamatsu K., Kuwae A., Konaka T., Nagai S., Yoshida S., Eguchi M., Watanabe M., Mimuro H., Koyasu S., Abe A. Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J. Exp. Med. 2009, 206:3073-3088.
69. + T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect. Immun. 2007, 75:2275-2282.
70. Niikura M., Kamiya S., Nakane A., Kita K., Kobayashi F. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites. Int. J. Parasitol. 2010, 40:101-108.
71. Nylen S., Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends. Immunol. 2007, 28:378-384.
72. O'Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 2008, 223:114-131.
73. Ocana-Morgner C., Mota M.M., Rodriguez A. Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 2003, 197:143-151.
74. Ong'echa J.M., Remo A.M., Kristoff J., Hittner J.B., Were T., Ouma C., Otieno R.O., Vulule J.M., Keller C.C., Awandare G.A., Perkins D.J. Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10. Clin. Immunol. 2008, 126:211-221.
75. Othoro C., Lal A.A., Nahlen B., Koech D., Orago A.S.S., Udhayakumar V. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 1999, 179:279-282.
76. Ouma C., Davenport G.C., Were T., Otieno M.F., Hittner J.B., Vulule J.M., Martinson J., Ong'echa J.M., Ferrell R.E., Perkins D.J. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum. Genet. 2008, 124:515-524.
77. + T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
78. Plebanski M., Flanagan K.L., Lee E.A., Reece W.H., Hart K., Gelder C., Gillespie G., Pinder M., Hill A.V. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 1999, 10:651-660.
79. Pot C., Jin H., Awasthi A., Liu S.M., Lai C.Y., Madan R., Sharpe A.H., Karp C.L., Miaw S.C., Ho I.C., Kuchroo V.K. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 2009, 183:797-801.
80. Powrie F., Read S., Mottet C., Uhlig H., Maloy K. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 2003, 252:92-98. (discussion 98-105, 106-114).
81. Praba-Egge A.D., Montenegro S., Cogswell F.B., Hopper T., James M.A. Cytokine responses during acute simian Plasmodium cynomolgi and Plasmodium knowlesi infections. Am. J. Trop. Med. Hyg. 2002, 67:586-596.
82. Prakash D., Fesel C., Jain R., Cazenave P.A., Mishra G.C., Pied S. Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J. Infect. Dis. 2006, 194:198-207.
83. Redford P.S., Boonstra A., Read S., Pitt J., Graham C., Stavropoulos E., Bancroft G.J., O'Garra A. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 2010, 40:2200-2210.
84. Roers A., Siewe L., Strittmatter E., Deckert M., Schluter D., Stenzel W., Gruber A.D., Krieg T., Rajewsky K., Muller W. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 2004, 200:1289-1297.
85. Roilides E., Anastasiou-Katsiardani A., Dimitriadou-Georgiadou A., Kadiltsoglou I., Tsaparidou S., Panteliadis C., Walsh T.J. Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus. J. Infect. Dis. 1998, 178:1734-1742.
86. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006, 212:28-50.
87. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 2001, 182:18-32.
88. Saraiva M., Christensen J.R., Veldhoen M., Murphy T.L., Murphy K.M., O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009, 31:209-219.
89. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
90. Schmidt-Weber C.B., Alexander S.I., Henault L.E., James L., Lichtman A.H. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J. Immunol. 1999, 162:238-244.
91. Scholzen A., Mittag D., Rogerson S.J., Cooke B.M., Plebanski M. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. PLoS Pathog. 2009, 5:e1000543.
92. + regulatory T cells. Immunol. Rev. 2006, 212:60-73.
93. Sinha S., Qidwai T., Kanchan K., Jha G.N., Anand P., Pati S.S., Mohanty S., Mishra S.K., Tyagi P.K., Sharma S.K., Awasthi S., Venkatesh V., Habib S. Distinct cytokine profiles define clinical immune response to falciparum malaria in regions of high or low disease transmission. Eur. Cytokine Netw. 2010, 21:232-240.
94. Sponaas A.M., Freitas do Rosario A.P., Voisine C., Mastelic B., Thompson J., Koernig S., Jarra W., Renia L., Mauduit M., Potocnik A.J., Langhorne J. Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood 2009, 114:5522-5531.
95. + regulatory T cells in the control of experimental cerebral malaria. J. Immunol. 2009, 183:7014-7022.
96. Stevenson M.M., Ing R., Berretta F., Miu J. Regulating the adaptive immune response to blood-stage malaria: role of dendritic cells and CD4Foxp3 regulatory T cells. Int. J. Biol. Sci. 2011, 7:1311-1322.
97. Struik S.S., Riley E.M. Does malaria suffer from lack of memory?. Immunol. Rev. 2004, 201:268-290.
98. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., Ernst M., Saris C.J., O'Shea J.J., Hunter C.A. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
99. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009, 15:277-284.
100. Thuma P.E., van Dijk J., Bucala R., Debebe Z., Nekhai S., Kuddo T., Nouraie M., Weiss G., Gordeuk V.R. Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. J. Infect. Dis. 2011, 203:211-219.
101. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5:e128.
102. Torcia M.G., Santarlasci V., Cosmi L., Clemente A., Maggi L., Mangano V.D., Verra F., Bancone G., Nebie I., Sirima B.S., Liotta F., Frosali F., Angeli R., Severini C., Sannella A.R., Bonini P., Lucibello M., Maggi E., Garaci E., Coluzzi M., Cozzolino F., Annunziato F., Romagnani S., Modiano D. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 2008, 105:646-651.
103. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J. Exp. Med. 2007, 204:239-243.
104. + T cells during cure of colitis. J. Immunol. 2006, 177:5852-5860.
105. Velavan T.P., Buyukyazici B., Kremsner P.G., Kun J.F. Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children. Immunogenetics 2012, 64:87-95.
106. + T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int. J. Parasitol. 2007, 37:963-973.
107. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
108. Walley A.J., Aucan C., Kwiatkowski D., Hill A.V. Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur. J. Hum. Genet. 2004, 12:132-138.
109. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005, 23:287-296.
110. Walther M., Jeffries D., Finney O.C., Njie M., Ebonyi A., Deininger S., Lawrence E., Ngwa-Amambua A., Jayasooriya S., Cheeseman I.H., Gomez-Escobar N., Okebe J., Conway D.J., Riley E.M. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009, 5:e1000364.
111. Webster K.E., Walters S., Kohler R.E., Mrkvan T., Boyman O., Surh C.D., Grey S.T., Sprent J. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 2009, 206:751-760.
112. Weidanz W.P., Batchelder J.M., Flaherty P., LaFleur G., Wong C., van der Heyde H.C. Plasmodium chabaudi adami: use of the B-cell-deficient mouse to define possible mechanisms modulating parasitemia of chronic malaria. Exp. Parasitol. 2005, 111:97-104.
113. Wilson J.N., Rockett K., Jallow M., Pinder M., Sisay-Joof F., Newport M., Newton J., Kwiatkowski D. Analysis of IL10 haplotypic associations with severe malaria. Genes Immun. 2005, 6:462-466.
114. Wilson N.O., Bythwood T., Solomon W., Jolly P., Yatich N., Jiang Y., Shuaib F., Adjei A.A., Anderson W., Stiles J.K. Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Infect. Dis. Obstet. Gynecol. 2010, 10.1155/2010/317430.
115. Winkler S., Willheim M., Baier K., Schmid D., Aichelburg A., Graninger W., Kremsner P.G. Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect. Immun. 1998, 66:6040-6044.
116. Wipasa J., Okell L., Sakkhachornphop S., Suphavilai C., Chawansuntati K., Liewsaree W., Hafalla J.C., Riley E.M. Short-lived IFN-gamma effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog. 2011, 7:e1001281.
117. Wu Y., Wang Q.H., Zheng L., Feng H., Liu J., Ma S.H., Cao Y.M. Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice. Exp. Parasitol. 2007, 115:301-304.
118. Xystrakis E., Boswell S.E., Hawrylowicz C.M. T regulatory cells and the control of allergic disease. Expert Opin. Biol. Ther. 2006, 6:121-133.
119. Zheng W., Wang Q.H., Liu Y.J., Liu J., Feng H., Wu J.J., Cao Y.M. Distinct host-related dendritic cell responses during the early stage of Plasmodium yoelii infection in susceptible and resistant mice. Parasite Immunol. 2010, 32:324-334.